Bullfrog AI Holdings, Inc. Common Stock
NASDAQ Capital MarketRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- BullFrog AI Holdings, Inc. is a technology-enabled digital biopharmaceutical company specializing in the use of advanced artificial intelligence and machine learning (AI/ML) to improve drug development and clinical trials. Founded in 2017 and headquartered in Gaithersburg, Maryland, BullFrog AI develops and markets its proprietary analytical AI/ML platform, bfLEAP™, which provides complex data analysis for preclinical and clinical datasets to identify high-value data niches and patient subgroups. The company's core products include the bfLEAP™ platform for drug discovery, clinical trial optimization, drug repurposing, and biomarker identification, along with the BullFrog Data Networks™ Solutions Library and the newly launched bfPREP™ module for automated data cleansing and standardization. BullFrog AI primarily serves biotechnology and pharmaceutical companies in the United States, leveraging AI to accelerate and de-risk drug discovery and development, particularly targeting diseases such as CNS disorders, hepatocellular carcinoma, obesity, and non-alcoholic fatty liver disease. Recent strategic developments include a major collaboration agreement with Sygnature Discovery to expand BullFrog AI's presence in international biopharma R&D markets, focusing on early-stage target discovery and precision medicine. In 2025, BullFrog AI has also launched the bfPREP™ module to enhance data processing capabilities and completed a registered direct offering raising approximately $3.13 million to fund ongoing platform development and operational expansion. The company has recognized initial commercial revenue in 2025 and continues to pursue partnerships and internal initiatives aimed at broadening the applications of its AI-driven technology in drug development. BullFrog AI's business model emphasizes AI-driven efficiency for biopharma R&D, targeting improved clinical outcomes, reduced costs, and precise patient stratification to transform drug discovery and clinical trial processes.
Company News
BullFrog AI to Present at the 20th Annual LD Micro Main Event on October 20, 2026
BullFrog AI Announces Positive Progress in Drug Discovery Program for Top 5 Global Pharmaceutical in Major Depressive Disorder
Financial Survey: Fortrea (NASDAQ:FTRE) vs. Bullfrog AI (NASDAQ:BFRG)
Is Bullfrog AI Holdings Inc. (BFRG) Outperforming Other Medical Stocks This Year?
Joshua Blacher Buys 50,000 Shares of Bullfrog AI (NASDAQ:BFRG) Stock
Vininder Singh Buys 75,000 Shares of Bullfrog AI (NASDAQ:BFRG) Stock
BullFrog AI Stock Surges Wednesday: What's Happening?
Contrasting IQVIA (NYSE:IQV) and Bullfrog AI (NASDAQ:BFRG)
Bullfrog AI Holdings, Inc. (BFRG) Presents at IAccess Alpha Virtual Best Ideas Fall Investment Conference 2026 Transcript
BullFrog AI to Participate in September 2026 Investor Conferences
BullFrog AI to Participate in the BTIG Virtual Biotechnology Conference
BullFrog AI to Participate in Water Tower Research Fireside Chat on Thursday, July 23, 2026
Water Tower Research Publishes Initiation of Coverage Report on BullFrog AI Holdings, Inc., "Helping Big Pharma Look Before It Leaps in Drug Discovery"
BullFrog AI Announces New Commercial Leadership Team to Execute Growth Strategy for its Integrated Pharma AI Platform
BullFrog AI Regains Compliance with Nasdaq Shareholders' Equity Requirement
BullFrog AI Announces Participation at AACR Annual Meeting
BullFrog AI Provides Business Update: Strengthened Balance Sheet Supports Continued Execution as Company Aims to Ramp Commercial Activity with Global Pharmaceutical and Biotechnology Partners
Bullfrog AI Holdings Inc. (NASDAQ:BFRG) Short Interest Down 15.0% in March
BullFrog AI Shares Surge On Deal With Top Pharma Company For MDD Drug Targets
Bullfrog AI stock offers a rare opportunity for investors to take profit